These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6336961)
41. The role of thiotepa in autologous bone marrow transplantation for acute leukemia. Nagler A; Finlander R; Or R; Naparstek E; Varadi G; Slavin S Leuk Res; 1998 Nov; 22(11):991-5. PubMed ID: 9783800 [TBL] [Abstract][Full Text] [Related]
42. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of lymphocyte subsets after autologous bone marrow transplantation with marrow treated by ASTA Z 7557 in acute leukemia: incidence of the in vitro treatment. Le Blanc G; Douay L; Laporte JP; Dominh A; Deloux J; Najman A; Duhamel G; Gorin NC Exp Hematol; 1986 Jun; 14(5):366-71. PubMed ID: 3519264 [TBL] [Abstract][Full Text] [Related]
44. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy. Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686 [TBL] [Abstract][Full Text] [Related]
45. Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation. Miller CB; Zehnbauer BA; Piantadosi S; Rowley SD; Jones RJ Blood; 1991 Aug; 78(4):1125-31. PubMed ID: 1868244 [TBL] [Abstract][Full Text] [Related]
46. Autologous bone marrow transplantation in leukemia. Netzel B; Haas RI; Thierfelder S Recent Results Cancer Res; 1984; 93():290-300. PubMed ID: 6382486 [TBL] [Abstract][Full Text] [Related]
47. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Gulati SC; Shank B; Sarris A; Berman E; Gee T; Cunningham I; Flomenberg N; O'Reilly RJ; Clarkson B Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485 [No Abstract] [Full Text] [Related]
49. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children]. Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274 [TBL] [Abstract][Full Text] [Related]
50. Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study. Laporte JP; Isnard F; Lesage S; Fenaux P; Douay L; Lopez M; Stachowiak J; Najman A; Gorin NC Leukemia; 1993 Dec; 7(12):2030-3. PubMed ID: 8255103 [TBL] [Abstract][Full Text] [Related]
51. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy. Körbling M; Hunstein W Blut; 1984 Apr; 48(4):189-99. PubMed ID: 6370338 [No Abstract] [Full Text] [Related]
52. [Autologous bone marrow transplantation in acute myeloid leukemias: a report of 7 cases]. Yan W Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):317-22. PubMed ID: 1839248 [TBL] [Abstract][Full Text] [Related]
53. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292 [TBL] [Abstract][Full Text] [Related]
54. Autologous PBSC transplant for late onset AML after mafosfamide-purged and TBI-containing autologous BMT. Bassan R; Cortelazzo S; Rambaldi A; Cornelli P; Borleri G; Bellavita P; Biondi A; Barbui T Bone Marrow Transplant; 1995 May; 15(5):791-3. PubMed ID: 7670409 [TBL] [Abstract][Full Text] [Related]
55. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Rohatiner AZ; Johnson PW; Price CG; Arnott SJ; Amess JA; Norton AJ; Dorey E; Adams K; Whelan JS; Matthews J J Clin Oncol; 1994 Jun; 12(6):1177-84. PubMed ID: 8201380 [TBL] [Abstract][Full Text] [Related]
56. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide. Perot C; van den Akker J; Laporte JP; Douay L; Lopez M; Stachowiak J; Isnard F; Taillemite JL; Najman A; Gorin NC Leukemia; 1993 Apr; 7(4):509-15. PubMed ID: 8464228 [TBL] [Abstract][Full Text] [Related]
57. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Helenglass G; Powles RL; McElwain TJ; Lakhani A; Milan S; Gore M; Nandi A; Zuiable A; Perren T; Forgeson G Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467 [TBL] [Abstract][Full Text] [Related]
58. Autologous bone marrow transplantation (ABMT) in acute myelogenous leukaemia--Heidelberg experience. Pai VR; Korbling M J Assoc Physicians India; 1990 Apr; 38(4):275-6. PubMed ID: 2202710 [TBL] [Abstract][Full Text] [Related]
59. Autologous bone marrow transplantation in acute myelogenous leukemia. Rizzoli V; Mangoni L; Carlo-Stella C Leukemia; 1992 Nov; 6(11):1101-6. PubMed ID: 1434791 [TBL] [Abstract][Full Text] [Related]
60. Standardization and characterization of the procedure for in vitro treatment of human bone marrow with cyclophosphamide derivatives. Lopez M; Du Puymontbrun MC; Douay L; Laporte JP; Gorin NC Clin Lab Haematol; 1985; 7(4):327-34. PubMed ID: 3913559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]